Vivioptal Protect
Natural health product licensed in Canada
- Licence holder
- Bomuca International Corporation
- NPN or DIN-HM
- 80056122
- Status
- Inactive licence
- Licence date
- 1 December 2014
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 100 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-arginine Source : L-arginine | 16.5 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 12 mcg | 12 µg |
| Vitamine D3 Source : Cholécalciférol Potency : 400 UI | 10 mcg | 10 µg |
| Vitamine E Source : d-alpha tocophérol Potency : 30 UI | 20.1 mg AT | Not calculated |
| Zinc Source : Oxyde de zinc | 10 mg | 10,000 µg |
| L-Lysine Source : Chlorhydrate de L-lysine | 13.2 mg | Not calculated |
| Biotine Source : Biotine | 27.7 mcg | 27.7 µg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl | 30 mg | Not calculated |
| Fallopia japonica Source : Racine Potency : 50 % Reveratrol | 100 mg | Not calculated |
| Fallopia japonica Source : standardized extract Potency : 50 % Reveratrol | 100 mg | Not calculated |
| Epimedium grandiflorum Source : Feuille et tige Potency : 10 % icarin | 30 mg | Not calculated |
| Epimedium grandiflorum Source : standardized extract Potency : 10 % icarin | 30 mg | Not calculated |
| Lycopène tout trans | 5 mg | Not calculated |
| Serenoa repens Source : Fruit (standardized extract) Potency : 0 85-95% fatty acids | 50 mg | Not calculated |
| Sélénium Source : Levure au sélénium | 100 mcg | 100 µg |
| Thiamine Source : Mononitrate de thiamine | 0.22 mg | 220 µg |
| Tribulus terrestris Source : Fruit (standardized extract) Potency : 40 % saponins | 20 mg | Not calculated |
| Vitamine A Source : Palmitate de rétinyle tout trans Potency : 2,000 UI | 604 mcg EAR | Not calculated |
Non-medicinal ingredients
Glycérine, FD&C Blue #1, Cire d'abeille, Gélatine, Ethyl Vanillin, Huile de fève de soja, Rouge FD&C N° 40, Huile de tournesol, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Gélule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth. Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps in the development maintenance of bones and teeth. Helps to form red blood cells. Helps in the absorption and use of calcium and phosphorus. An antioxidant for the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Helps to maintain and/or support cardiovascular health. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80056122
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.